These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27075449)

  • 1. Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes.
    Leclair E; Liggins RT; Peckett AJ; Teich T; Coy DH; Vranic M; Riddell MC
    Diabetologia; 2016 Aug; 59(8):1724-31. PubMed ID: 27075449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can somatostatin antagonism prevent hypoglycaemia during exercise in type 1 diabetes?
    Taleb N; Rabasa-Lhoret R
    Diabetologia; 2016 Aug; 59(8):1632-5. PubMed ID: 27153841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic rats.
    Yue JT; Burdett E; Coy DH; Giacca A; Efendic S; Vranic M
    Diabetes; 2012 Jan; 61(1):197-207. PubMed ID: 22106159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological assessment of pancreatic islet hormone content following aerobic exercise training in rats with poorly controlled Type 1 diabetes mellitus.
    McDonald MW; Murray MR; Hall KE; Noble EG; Melling CW
    Islets; 2014; 6(2):e29221. PubMed ID: 25483959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of somatostatin receptor type 2 antagonism during insulin-induced hypoglycaemia in male rats with prediabetes.
    Hoffman EG; D'Souza NC; Aiken J; Atherley S; Liggins R; Riddell MC
    Diabetes Obes Metab; 2023 Jun; 25(6):1547-1556. PubMed ID: 36734462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats.
    Yue JT; Riddell MC; Burdett E; Coy DH; Efendic S; Vranic M
    Diabetes; 2013 Jul; 62(7):2215-22. PubMed ID: 23434929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin Receptor Antagonism Reverses Glucagon Counterregulatory Failure in Recurrently Hypoglycemic Male Rats.
    Hoffman EG; Jahangiriesmaili M; Mandel ER; Greenberg C; Aiken J; D'Souza NC; Pasieka A; Teich T; Chan O; Liggins R; Riddell MC
    Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34477204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glucoregulatory response to high-intensity aerobic exercise following training in rats with insulin-treated type 1 diabetes mellitus.
    McDonald MW; Murray MR; Grise KN; Olver TD; Dey A; Shoemaker JK; Noble EG; Melling CW
    Appl Physiol Nutr Metab; 2016 Jun; 41(6):631-9. PubMed ID: 27175938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZT-01: A novel somatostatin receptor 2 antagonist for restoring the glucagon response to hypoglycaemia in type 1 diabetes.
    Farhat R; Aiken J; D'Souza NC; Appadurai D; Hull G; Simonson E; Liggins RT; Riddell MC; Chan O
    Diabetes Obes Metab; 2022 May; 24(5):908-917. PubMed ID: 35060297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.
    Karimian N; Qin T; Liang T; Osundiji M; Huang Y; Teich T; Riddell MC; Cattral MS; Coy DH; Vranic M; Gaisano HY
    Diabetes; 2013 Aug; 62(8):2968-77. PubMed ID: 23630299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon response to hypoglycemia is improved by insulin-independent restoration of normoglycemia in diabetic rats.
    Shi ZQ; Rastogi KS; Lekas M; Efendic S; Drucker DJ; Vranic M
    Endocrinology; 1996 Aug; 137(8):3193-9. PubMed ID: 8754739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic sodium salicylate feeding on the impaired glucagon and epinephrine responses to insulin-induced hypoglycaemia in streptozotocin diabetic rats.
    Patel DG; Skau KA
    Diabetologia; 1989 Jan; 32(1):61-6. PubMed ID: 2707517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia.
    Porcellati F; Pampanelli S; Rossetti P; Busciantella Ricci N; Marzotti S; Lucidi P; Santeusanio F; Bolli GB; Fanelli CG
    Diabetologia; 2007 Feb; 50(2):422-30. PubMed ID: 17160672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a heavy exercise program on the distribution of pancreatic hormones in the streptozotocin-induced diabetic rat.
    Howarth FC; Marzouqi FM; Al Saeedi AM; Hameed RS; Adeghate E
    JOP; 2009 Sep; 10(5):485-91. PubMed ID: 19734622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention.
    GhavamiNejad A; Lu B; Samarikhalaj M; Liu JF; Mirzaie S; Pereira S; Zhou L; Giacca A; Wu XY
    Drug Deliv Transl Res; 2022 Apr; 12(4):792-804. PubMed ID: 33683625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recurrent hyperinsulinemia with and without hypoglycemia on counterregulation in diabetic rats.
    Inouye K; Shum K; Chan O; Mathoo J; Matthews SG; Vranic M
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1369-79. PubMed ID: 12006368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models.
    Hvid H; Brand CL; Hummelshøj T; Jensen S; Bouman SD; Bowler A; Poulsen BR; Tiainen P; Åkertröm T; Demozay D; Hoeg-Jensen T; Ingvorsen C; Pedersen TÅ; McGuire J; Egebjerg T; Cappelen KA; Eliasen IP; Hansen BF; Hennen S; Stidsen CE; Olsen GS; Roed NK
    Diabetologia; 2023 Feb; 66(2):376-389. PubMed ID: 36404376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats.
    Farhy LS; Du Z; Zeng Q; Veldhuis PP; Johnson ML; Brayman KL; McCall AL
    Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E575-85. PubMed ID: 18577688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon secretory response to hypoglycaemia, adrenaline and carbachol in streptozotocin-diabetic rats.
    Ahrén B; Stern JS; Gingerich RL; Curry DL; Havel PJ
    Acta Physiol Scand; 1995 Oct; 155(2):215-21. PubMed ID: 8669294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An insulin-dependent hypoglycaemia induced by electroacupuncture at the Zhongwan (CV12) acupoint in diabetic rats.
    Chang SL; Lin JG; Chi TC; Liu IM; Cheng JT
    Diabetologia; 1999 Feb; 42(2):250-5. PubMed ID: 10064107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.